Application of pathological indicators based on liver biopsy in the diagnosis of cirrhotic portal hypertension
10.3969/j.issn.1001-5256.2021.12.042
- VernacularTitle:肝活检病理学指标在肝硬化门静脉高压症诊断中的应用
- Author:
Yajie XU
1
,
2
;
Wenzheng YOU
3
;
Wanlei REN
4
;
Quanhe LONG
5
;
Xiangjun JIANG
2
;
Doudou HU
2
Author Information
1. Graduate School of Dalian Medical University, Dalian, Liaoning 116044, China
2. Second Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong 266000, China
3. Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong 266000, China
4. First Department of Traditional Chinese Medicine, Qingdao Central Hospital Affiliated to Qingdao University, Qingdao, Shandong 266042, China
5. Department of General Surgery, Qingdao Municipal Hospital, Qingdao, Shandong 266000, China
- Publication Type:Reviews
- Keywords:
Liver Cirrhosis;
Hypertension, Portal;
Biopsy, Needle;
Diagnosis
- From:
Journal of Clinical Hepatology
2021;37(12):2935-2938
- CountryChina
- Language:Chinese
-
Abstract:
Hepatic venous pressure gradient (HVPG) is the "gold standard" for diagnosing portal hypertension and determining its severity, but its wide clinical application is limited due to its invasiveness and difficulties in operation. The replacement of HVPG by noninvasive methods has become a research hotspot in recent years; however, the accuracy of the existing serological and imaging methods remains to be discussed, and such methods cannot completely replace HVPG in clinical practice. Liver biopsy has been widely used in clinical practice for many years and is still an indispensable method for the diagnosis of some liver diseases. Recent studies have found that several pathological indicators after liver biopsy, such as collagen area, fibrous septal thickness, nodule size, microvascular density, and density and area of bile ducts and lymphatic vessels, can not only judge the severity of liver fibrosis, but also have a good correlation with portal venous pressure, which provides new ideas for diagnosing cirrhotic portal hypertension and evaluating the severity of portal hypertension.
